Stockscreener 앱 받기
3.99
1.48%
-0.06
시간 외 거래:
3.99
전일 마감가:
$4.05
열려 있는:
$4.14
하루 거래량:
45,190
Relative Volume:
0.41
시가총액:
$25.02M
수익:
-
순이익/손실:
$-4.69M
주가수익비율:
-1.7124
EPS:
-2.33
순현금흐름:
$-3.81M
1주 성능:
-8.06%
1개월 성능:
-4.77%
6개월 성능:
+250.00%
1년 성능:
+101.00%
1일 변동 폭
$3.95
$4.15
1주일 범위
$3.95
$4.40
52주 변동 폭
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
명칭
Lixte Biotechnology Holdings Inc
전화
310 203 2902
주소
433 PLAZA REAL, BOCA RATON
LIXT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.99 | 25.40M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lixte Biotechnology Holdings Inc 주식(LIXT)의 최신 뉴스
Lixte Biotechnology shareholders approve board nominees and stock plan amendment - Investing.com
Lixte Biotechnology shareholders approve board nominees and stock plan amendment By Investing.com - Investing.com South Africa
Lixte Biotechnology Holds Annual Meeting, Approves Key Issues - TipRanks
Lixte’s Big Bet: Making Other Cancer Drugs Work Harder - InvestorNews
LIXTE (NASDAQ: LIXT) expands oncology platform with LiGHT proton therapy system - Stock Titan
Lixte Biotechnology (LIXT) Stock Analysis Report | Financials & Insights - Benzinga
Meme Stocks: Will Lixte Biotechnology Holdings Inc stock maintain momentum in 2025Quarterly Trade Report & Free Weekly Watchlist of Top Performers - moha.gov.vn
Lixte Biotechnology shares slide following purchase of UK-based Liora - MSN
Is Lixte Biotechnology Holdings Inc. (8640) stock a buy on weaknessWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
Will Lixte Biotechnology Holdings Inc. stock maintain momentum in 2025Market Trend Summary & Daily Oversold Stock Bounce Ideas - Newser
What sentiment indicators say about Lixte Biotechnology Holdings Inc. stockJuly 2025 EndofMonth & Fast Momentum Entry Tips - Newser
Is Lixte Biotechnology Holdings Inc. (8640) stock undervalued historicallyQuarterly Trade Summary & Real-Time Volume Surge Alerts - Newser
Can Lixte Biotechnology Holdings Inc. stock deliver consistent earnings growthJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser
Published on: 2025-12-04 00:03:12 - Newser
LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology - Yahoo Finance
LIXTE (NASDAQ: LIXT) advances LB-100 combos with GSK, Roche and refines long-term strategy - Stock Titan
LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers - Yahoo Finance
Will Lixte Biotechnology Holdings Inc. (8640) stock rise with strong economy2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
There is no doubt that Lixte Biotechnology Holdings Inc (LIXT) ticks all the boxes. - Setenews
Lixte Biotechnology Acquires Liora Technologies for Growth - TipRanks
LIXTE Biotechnology acquires UK-based proton therapy developer Liora By Investing.com - Investing.com Nigeria
Lixte Biotechnology stock falls after acquiring UK-based Liora By Investing.com - Investing.com
Lixte Biotechnology stock falls after acquiring UK-based Liora - Investing.com
LIXTE Biotechnology (LIXT) Expands with Acquisition of Liora Tec - GuruFocus
LIXTE Biotechnology acquires UK-based proton therapy developer Liora - Investing.com India
LIXTE Biotechnology Holdings, Inc. Completes Acquisition of Liora Technologies Europe Ltd. to Advance Proton Therapy Treatment for Cancer - Quiver Quantitative
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment - InvestorNews
S&P 500, Dow and NASDAQ end day on positive note as Wall Street begins Thanksgiving week on high with boos - The Economic Times
Lixte Biotechnology announces $5M equity financing; shares down - MSN
Will Upside Catalysts Materialize for Vallabh Steels Limited in YEARGrowth Stock Opportunities & Small Capital Investment Tips - earlytimes.in
Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants By Investing.com - Investing.com Australia
Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants - Investing.com UK
Lixte Biotechnology Holdings Inc. (LIXT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Key Metrics Every Investor Should Know About Shree Hari Chemicals Export Limited - earlytimes.in
Will Lixte Biotechnology Holdings Inc. Equity Warrant stock benefit from automation - newser.com
Can Lixte Biotechnology Holdings Inc. stock maintain growth trajectory2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock positioned well for digital economy2025 Short Interest & Low Drawdown Investment Strategies - newser.com
Can Lixte Biotechnology Holdings Inc. Equity Warrant stock sustain market leadership2025 Top Gainers & Free Weekly Watchlist of Top Performers - newser.com
Will Lixte Biotechnology Holdings Inc. stock attract ESG investorsTake Profit & Growth Focused Stock Pick Reports - newser.com
Will Lixte Biotechnology Holdings Inc. (8640) stock hit analyst forecasts2025 Macro Impact & Safe Entry Momentum Stock Tips - newser.com
Is Lixte Biotechnology Holdings Inc. stock a safe buy before earnings2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
Is Lixte Biotechnology Holdings Inc. (8640) stock a buy during volatile marketsJuly 2025 Highlights & Fast Entry High Yield Tips - newser.com
Is Lixte Biotechnology Holdings Inc. stock resilient to inflation2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant trending in predictive chart modelsJuly 2025 Intraday Action & Daily Volume Surge Trade Alerts - newser.com
Market reaction to Lixte Biotechnology Holdings Inc.’s recent news - newser.com
How risky is Lixte Biotechnology Holdings Inc. Equity Warrant stock now2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
Lixte Biotechnology Holdings Inc (LIXT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
1.05%
자본화:
|
볼륨(24시간):